Table 2. Change in MDT decision-making without (Decision 1) and with (Decision 2) the IHC4+C score.
| Decision 1 | Decision 2 | |
|---|---|---|
| Endocrine therapy | 50 (40%) | 82 (66%) |
| Discuss chemotherapy | 45 (36%) | 0 |
| Recommend chemotherapy | 29 (23%) | 42 (34%) |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.